期刊文献+

胰腺癌血清差异蛋白表达谱

Serum proteome profiling of pancreatic adenocarcinoma
下载PDF
导出
摘要 目的通过胰腺癌患者血清差异蛋白表达谱鉴定胰腺癌的血清学生物标志物。方法用固相配体文库技术处理胰腺癌及非癌对照的血清,二维电泳技术分析差异点、串联质谱鉴定与胰腺癌变相关的血清差异蛋白质分子;用ELISA检测血清中凝集素的表达。结果 7种蛋白质分子在胰腺癌患者血清中的表达量升高,包括凝集素、玻连蛋白、补体C4-A、维生素蛋白D结合蛋白、抗凝血酶Ⅲ、补体C6和凝血酶原;补体C7血清表达量下降。胰腺癌患者血清凝集素水平为674±49 mg/L,显著高于非癌对照组的224±25 mg/L(P<0.05)。结论凝集素可能与胰腺癌的发生、发展过程密切相关,血清凝集素检测可能是重要的胰腺癌诊断生物标志物。 Objective To identify biomarkers involved in pancreatic adenocarcinoma by serum proteome fingerprinting.Methods ProteoMiner beads were used to treat neat serum sample of pancreatic cancer and control tissues followed by 2-D gel electrophoresis and ESI-MS/MS to identify the signature proteins involved in pancreatic carcinogenesis.ELISA was used to determine serum level of clusterin.Results Seven proteins including clusterin,vitronectin,complement C4-A,vitamin D-binding protein,anitthrombin-Ⅲ,complement component C and prothrombin were up-regulated and complement component C7 was down-regulaed in serum of pancreatic cancer.ELISA results showed that serum level of clusterin enhanced in pancreatic adenocarcinoma significantly(P0.05).ConclusionsClusterin may correlate closely with development and progression of pancreatic adenocarcinoma and serum level of clusterin may serve as a key biomarker for diagnosis of pancreatic adenocarcinoma.
出处 《基础医学与临床》 CSCD 北大核心 2012年第4期433-436,共4页 Basic and Clinical Medicine
基金 河南省医学科技攻关项目(2011020017)
关键词 胰腺癌 高丰度蛋白 低丰度蛋白 凝集素 补体 pancreatic adenocarcinoma high-abundance proteins low-abundance proteins clusterin complement
  • 相关文献

参考文献11

  • 1Li D,Xie K,Wolff R,et al.Pancreatic cancer[J].Lan-cet,2004,363:1049-1057.
  • 2Jemal A,Murray T,WardE,et al.Cancer statistics,2005[J].CA Cancer J Clin,2005,55:10-30.
  • 3Pelaez-Luna M,Takahashi N,Fletcher JG,et al.Resect-ability of presymptomatic pancreatic cancer and its relation-ship to onset of diabetes:a retrospective review of CT scansand fasting glucose values prior to diagnosis[J].Am J Gas-troenterol,2007,102:2157-2163.
  • 4Akdogan M,Sasmaz N,Kayhan B,et al.Extraordinarilyelevated CA19-9 in benign conditions:a case report and re-view of the literature[J].Tumori,2001,87:337-339.
  • 5Ni XG,Bai XF,Mao YL,et al.The clinical value of serumCEA,CA19-9,and CA242 in the diagnosis and prognosisof pancreatic cancer[J].Eur J Surg Oncol,2005,31:164-169.
  • 6廖秋林,陈晓东,丁彦青.血清蛋白质组学技术及研究进展[J].中国病理生理杂志,2008,24(2):402-407. 被引量:22
  • 7Min BH,Kim BM,Lee SH,et al.Clusterin expression inthe early process of pancreas regeneration in the pancreatec-tomized rat[J].J Histochem Cytochem,2003,51:1355-1365.
  • 8Xie MJ,Motoo Y,Su SB,et al.Expression of clusterin inhuman pancreatic cancer[J].Pancreas,2002,25:234-238.
  • 9Mourra N,Couvelard A,Tiret E,et al.Clusterin is higly ex-pressed in pancreatic endocrine tumours but not in solidpseudopapillary tumors[J].Histopathology,2007,50:331-337.
  • 10Park IS,Che YZ,Bendayan M,et al.Up-regulation of clus-terin(sulfated glycoprotein-2)in pancreatic islets cellsupon streptozotocin injection to rats[J].J Endocrinol,1999,162:57-65.

二级参考文献21

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部